Advertisement

Topics

400 jobs to go as Novo Nordisk overhauls R&D operations

05:29 EDT 18 Sep 2018 | Pharmafile

Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and diversification of its pipeline across serious chronic diseases”. This move, of course, does not come without restructuring, and will result in the loss of 400 employees.

The company confirmed that these roles would be cut from its operations in China and Denmark.

read more

Original Article: 400 jobs to go as Novo Nordisk overhauls R&D operations

NEXT ARTICLE

More From BioPortfolio on "400 jobs to go as Novo Nordisk overhauls R&D operations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...